Terms: = Breast cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src
1905 results:
1. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
[TBL] [Abstract] [Full Text] [Related]
2. N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-src kinase inhibitors with prominent antitumor activity.
Awaji AA; Zaloa WAZE; Seleem MA; Alswah M; Elsebaei MM; Bayoumi AH; El-Morsy AM; Alfaifi MY; Shati AA; Elbehairi SEI; Almaghrabi M; Aljohani AKB; Ahmed HEA
Bioorg Chem; 2024 Apr; 145():107228. PubMed ID: 38422592
[TBL] [Abstract] [Full Text] [Related]
3. Superbinder based phosphoproteomic landscape revealed PRKCD_pY313 mediates the activation of src and p38 MAPK to promote TNBC progression.
Deng Y; Hou Z; Li Y; Yi M; Wu Y; Zheng Y; Yang F; Zhong G; Hao Q; Zhai Z; Wang M; Ma X; Kang H; Ji F; Dong C; Liu H; Dai Z
Cell Commun Signal; 2024 Feb; 22(1):115. PubMed ID: 38347536
[TBL] [Abstract] [Full Text] [Related]
4. Emerging Roles of YES1 in cancer: The Putative Target in Drug Resistance.
Kook E; Chun KS; Kim DH
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338729
[TBL] [Abstract] [Full Text] [Related]
5. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
6. Tyrosine phosphorylation-mediated YAP1-TFAP2A interactions coordinate transcription and trastuzumab resistance in HER2+ breast cancer.
Zou H; Luo J; Guo Y; Deng L; Zeng L; Pan Y; Li P
Drug Resist Updat; 2024 Mar; 73():101051. PubMed ID: 38219531
[TBL] [Abstract] [Full Text] [Related]
7. Integrative analysis of transcriptomic and metabolomic profiles reveals enhanced arginine metabolism in androgen-independent prostate cancer cells.
Dai X; Shi X; Luo M; Li P; Gao Y
BMC Cancer; 2023 Dec; 23(1):1241. PubMed ID: 38104097
[TBL] [Abstract] [Full Text] [Related]
8. Active Gα
Lyu C; Bhimani AK; Draus WT; Weigel R; Chen S
Mol Cell Biol; 2023; 43(12):650-663. PubMed ID: 38099640
[TBL] [Abstract] [Full Text] [Related]
9. Design and synthesis of dual BRD4/src inhibitors for treatment of triple-negative breast cancer.
Wang Y; Huang A; Chen L; Sun F; Zhao M; Zhang M; Xie Y; Xu S; Li M; Hong L; Li G; Wang R
Eur J Med Chem; 2024 Jan; 264():116009. PubMed ID: 38070430
[TBL] [Abstract] [Full Text] [Related]
10. SHC4 orchestrates β-catenin pathway-mediated metastasis in triple-negative breast cancer by promoting src kinase autophosphorylation.
Zhong W; Jian Y; Zhang C; Li Y; Yuan Z; Xiong Z; Huang W; Ouyang Y; Chen X; Song L; Liu P; Wang X
Cancer Lett; 2024 Feb; 582():216516. PubMed ID: 38052369
[TBL] [Abstract] [Full Text] [Related]
11. Metabolomic Rewiring Promotes Endocrine Therapy Resistance in breast cancer.
Ahn S; Park JH; Grimm SL; Piyarathna DWB; Samanta T; Putluri V; Mezquita D; Fuqua SAW; Putluri N; Coarfa C; Kaipparettu BA
Cancer Res; 2024 Jan; 84(2):291-304. PubMed ID: 37906431
[TBL] [Abstract] [Full Text] [Related]
12. Discovery of imidazopyridine-pyrazoline-hybrid structure as SHP-1 agonist that suppresses phospho-STAT3 signaling in human breast cancer cells.
Yang MH; Sethi G; Ravish A; Mohan AK; Pandey V; Lobie PE; Basappa S; Basappa B; Ahn KS
Chem Biol Interact; 2023 Dec; 386():110780. PubMed ID: 37879592
[TBL] [Abstract] [Full Text] [Related]
13. An ULK1/2-PXN mechanotransduction pathway suppresses breast cancer cell migration.
Liang P; Zhang J; Wu Y; Zheng S; Xu Z; Yang S; Wang J; Ma S; Xiao L; Hu T; Jiang W; Huang C; Xing Q; Kundu M; Wang B
EMBO Rep; 2023 Nov; 24(11):e56850. PubMed ID: 37846507
[TBL] [Abstract] [Full Text] [Related]
14. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
15. Vascular endothelial growth factor antagonist peptides inhibit tumor growth and metastasis in breast cancer through repression of c-src and STAT3 genes.
Bejari M; Sasani ST; Asghari SM; Kolshan MN
Mol Biol Rep; 2023 Nov; 50(11):9213-9219. PubMed ID: 37789224
[TBL] [Abstract] [Full Text] [Related]
16. A curcumin-nicotinoyl derivative and its transition metal complexes: synthesis, characterization, and
Hosseini MS; Hadadzadeh H; Mirahmadi-Zare SZ; Farrokhpour H; Aboutalebi F; Morshedi D
Dalton Trans; 2023 Oct; 52(40):14477-14490. PubMed ID: 37779393
[TBL] [Abstract] [Full Text] [Related]
17. Mechanisms of breast cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
Semenza GL
Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
[TBL] [Abstract] [Full Text] [Related]
18. AIB1/src-3/NCOA3 function in estrogen receptor alpha positive breast cancer.
Kiliti AJ; Sharif GM; Martin MB; Wellstein A; Riegel AT
Front Endocrinol (Lausanne); 2023; 14():1250218. PubMed ID: 37711895
[TBL] [Abstract] [Full Text] [Related]
19. Suppressing src-Mediated EGFR Signaling by Sustained Calcium Supply Targeting Triple-Negative breast cancer.
Jeong KY; Park SY; Park MH; Kim HM
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686097
[TBL] [Abstract] [Full Text] [Related]
20. Claudin-10 in the Blood Brain Barrier Function of Cerebral Endothelial Cells and Transendothelial Invasion of breast cancer Cells.
Zhuang X; Ji W; Fang Z; Yang Y; Ruge F; Dou QP; Li X; Xu B; Jiang WG; Martin TA
Anticancer Res; 2023 Sep; 43(9):3923-3934. PubMed ID: 37648330
[TBL] [Abstract] [Full Text] [Related]
[Next]
